New pulmonary fibrosis inhalation therapy shows promise in mouse model
Lung stem cell secretions – nanosized exosomes and secretomes – delivered via a nebulizer has been shown to help in the repair of lung injuries from pulmonary fibrosis in mice and rats in research led by a team from North Carolina State University (NC State; USA). Pulmonary fibrosis is a fatal and incurable disease characterized by a thickening and scarring of healthy lung tissue, inflammation and replacement of lung cells with fibrotic tissue. The current treatment options for pulmonary fibrosis are severely limited and not very effective apart from highly invasive lung transplants. To rectify this, Ke Cheng of NC...
To view this content, please register now for access
Join our member community for FREE to access a collection of journal and online-only features, including:
- Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
- The latest news and journal updates delivered straight to your inbox when you want it
- Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
- Priority registration to webinars, panel discussions and events
- Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!
